Talnetant hydrochlorideProduct ingredient for Talnetant

Name
Talnetant hydrochloride
Drug Entry
Talnetant

Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.

Accession Number
DBSALT002012
Structure
Synonyms
Not Available